ANI Pharmaceuticals Closes Transaction to Acquire Two NDAs from Merck for $75 Million
4:19 PMJanuary 5, 2016– NDA #008975 Purified Cortrophin Gel, 40 units/mL and 80 units/mL – NDA #009854 Cortrophin-Zinc hydroxide, 40 units/mL BAUDETTE, Minn., Jan. 5, 2016, ANIP, /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that it has completed the acquisition of the NDAs for purified corticotropin gel and corticotropin zinc hydroxide from Merck (known as MSD outside of the United States and Canada) for $75 million in cash and a percentage of future net sales. The acquisition was funded through
Read more